SAFEHEART risk-equation and cholesterol-year-score are powerful predictors of cardiovascular events in French patients with familial hypercholesterolemia

2020/07/06 by Antonio Gallo, Sybil Charriere, Alexandre Vimont +43 · 15 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Lipoproteins and Cardiovascular Health #Diabetes, Cardiovascular Risks, and Lipoproteins #Cancer, Lipids, and Metabolism

paper · doi:10.1016/j.atherosclerosis.2020.06.011

Cited by

• Past, Present, and Future of Familial Hypercholesterolemia Management. [europepmc]
• Myocardial fibrosis assessed by magnetic resonance imaging in asymptomatic heterozygous familial hypercholesterolemia: the cholcoeur study. [europepmc]
• Relations of physical signs to genotype, lipid and inflammatory markers, coronary stenosis or calcification, and outcomes in patients with heterozygous familial hypercholesterolemia. [europepmc]
• The Role of Cumulative LDL Cholesterol in Cardiovascular Disease Development in Patients with Familial Hypercholesterolemia. [europepmc]
• Low-density lipoprotein cholesterol levels exceed the recommended European threshold for PCSK9i initiation: lessons from the HEYMANS study. [europepmc]
• Assessment of Associations Between Serum Lipoprotein (a) Levels and Atherosclerotic Vascular Diseases in Hungarian Patients With Familial Hypercholesterolemia Using Data Mining and Machine Learning. [europepmc]
• Familial Hypercholesterolemia and Elevated Lipoprotein(a): Cascade Testing and Other Implications for Contextual Models of Care. [europepmc]
• Burden of cardiovascular disease in a large contemporary cohort of patients with heterozygous familial hypercholesterolemia. [europepmc]
• Atherosclerosis severity in patients with familial hypercholesterolemia: The role of T and B lymphocytes. [europepmc]
• Impact of the severe familial hypercholesterolemia status on atherosclerotic risks. [europepmc]
• Peripheral artery disease: an underdiagnosed condition in familial hypercholesterolemia? A systematic review. [europepmc]
• Quo Vadis after AEGIS: New Opportunities for Therapies Targeted at Reverse Cholesterol Transport? [europepmc]
• LDL cholesterol burden in elderly patients with familial hypercholesterolemia: Insights from real-world data. [europepmc]
• A miRNA signature linked to high lipoprotein (a) and coronary calcification in familial hypercholesterolaemia. [europepmc]
• Whole exome sequencing and 12-SNP LDL polygenic score in South Indian patients with familial hypercholesterolemia. [europepmc]